Valsartan is a medication primarily used for the treatment of high blood pressure (hypertension), heart failure, and to improve survival after a heart attack. It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). ARBs work by blocking the action of a natural substance in the body that narrows blood vessels, thereby allowing blood to flow more smoothly and the heart to pump more efficiently. Valsartan is available as an oral tablet and is usually taken once or twice daily. It is not typically used as a first-line treatment for uncomplicated hypertension but may be preferred in patients who cannot tolerate ACE inhibitors due to cough (Mayo Clinic). Its half-life in the body is approximately 6 hours, meaning it takes about 6 hours for half of the drug to be eliminated from the body. The typical timing for administration is in the morning, and it can be taken with or without food. Valsartan is a prescription medication and its use requires a licensed clinician's supervision.
Deep dive
Tap a section to expand.
Known interactions
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Category rule: vitamin × medication
Note
Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).
Specific pairs are checked against a licensed source; confirm with your provider.
Compound-pair rule
Caution
PDE5 inhibitors add to the blood-pressure-lowering effect of antihypertensives.
Start PDE5 at the lowest effective dose and monitor for hypotension.
Compound-pair rule
Caution
PDE5 inhibitors add to the blood-pressure-lowering effect of antihypertensives.
Start PDE5 at the lowest effective dose and monitor for hypotension.
Compound-pair rule
Caution
PDE5 inhibitors add to the blood-pressure-lowering effect of antihypertensives.
Start PDE5 at the lowest effective dose and monitor for hypotension.
Frequently asked
Sources referenced
* DrugBank
* U.S. National Library of Medicine (MedlinePlus)
* NIH Office of Dietary Supplements (NIH ODS)
* Mayo Clinic
* PubChem
* U.S. Food and Drug Administration (FDA label information)
* European Medicines Agency (EMA SmPC documents)
* Cochrane Library
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the medication category or studied for the same goals.